Yubo International Biotech Limited (YBGJ)

USD 0.08

(56.51%)

Revenue Summary of Yubo International Biotech Limited

  • Yubo International Biotech Limited's latest annual revenue in 2022 was 104.28 Thousand USD , down -91.62% from previous year.
  • Yubo International Biotech Limited's latest quarterly revenue in 2023 Q2 was 1430.00 USD , down -99.09% from previous quarter.
  • Yubo International Biotech Limited reported a annual revenue of 1.24 Million USD in annual revenue 2021, down -8.09% from previous year.
  • Yubo International Biotech Limited reported a annual revenue of 1.35 Million USD in annual revenue 2020, down 0.0% from previous year.
  • Yubo International Biotech Limited reported a quarterly revenue of 1430.00 USD for 2023 Q2, down -99.09% from previous quarter.
  • Yubo International Biotech Limited reported a quarterly revenue of 66.52 Thousand USD for 2022 Q4, up 356.24% from previous quarter.

Annual Revenue Chart of Yubo International Biotech Limited (2022 - 2003)

Created with Highcharts 11.1.0YearsRevenue20042006200820102012201420162018202020220 USD500000 USD1000000 USD1500000 USD

Historical Annual Revenue of Yubo International Biotech Limited (2022 - 2003)

Year Revenue Revenue Growth
2022 104.28 Thousand USD -91.62%
2021 1.24 Million USD -8.09%
2020 1.35 Million USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD -100.0%
2014 60 Thousand USD -7.69%
2013 65 Thousand USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%

Peer Revenue Comparison of Yubo International Biotech Limited

Name Revenue Revenue Difference
American Medical Technologies Inc. 3.19 Million USD 96.732%
Ansell Limited 1.61 Billion USD 99.994%
Ansell Limited 1.61 Billion USD 99.994%
BG Medicine, Inc. - USD -Infinity%
Biotage AB (publ) 184.64 Million USD 99.944%
BioLife Sciences Inc. - USD -Infinity%
CB Scientific, Inc. 135.05 Thousand USD 22.785%
Psykey, Inc. 419.29 Thousand USD 75.129%
ConvaTec Group Plc 2.19 Billion USD 99.995%
ConvaTec Group Plc 2.14 Billion USD 99.995%
Encision Inc. 6.58 Million USD 98.417%
Golden Valley Development, Inc - USD -Infinity%
Hear AtLast Holdings, Inc. - USD -Infinity%
Innovative MedTech Inc. 1.82 Million USD 94.286%
LifePoint, Inc. -18.5 Thousand USD 663.692%
Medite Cancer Diagnostics, Inc. 6.81 Million USD 98.469%
Paradigm Medical Industries, Inc. 772 Thousand USD 86.492%
QuantRx Biomedical Corporation - USD -Infinity%
Remedent, Inc. 986.22 Thousand USD 89.426%
Reflect Scientific, Inc. 1.08 Million USD 90.346%
SmileDirectClub, Inc. 470.74 Million USD 99.978%
Sector 10, Inc. - USD -Infinity%
Shandong Weigao Group Medical Polymer Company Limited 1.87 Billion USD 99.994%
SheerVision, Inc. 3.49 Million USD 97.02%
United Health Products, Inc. - USD -Infinity%
Vasamed, Inc. 1.38 Million USD 92.478%
Wearable Health Solutions, Inc. 745.09 Thousand USD 86.004%